Pathogenesis of diabetic nephropathy

被引:5
作者
Chowdhury, TA [1 ]
Barnett, AH [1 ]
Bain, SC [1 ]
机构
[1] BIRMINGHAM HEARTLANDS HOSP, BIRMINGHAM B9 5SS, W MIDLANDS, ENGLAND
关键词
ATRIAL-NATRIURETIC-PEPTIDE; CONVERTING-ENZYME GENE; INITIAL RENAL GROWTH; UNINEPHRECTOMIZED RATS; KIDNEY-DISEASE; SOMATOMEDIN-C; END-PRODUCTS; INSULIN; MELLITUS; MICROALBUMINURIA;
D O I
10.1016/S1043-2760(96)00152-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is the most important long-term complication of diabetes mellitus and is a major cause of end-stage renal disease. The condition is associated with excess cardiovascular morbidity and mortality, as well as other diabetic microvascular complications. The etiopathogenesis of diabetic nephropathy appears to involve both genetic and environmental factors leading to disease in a subgroup of patients. Improved knowledge of the natural history and pathophysiology of the condition have enabled therapeutic strategies to be employed that have improved the outlook for patients with nephropathy. Strategies aimed at the identification of patients at high risk of nephropathy could have a major impact on the overall cardiovascular and renal morbidity in diabetic patients. (C) 1996, Elsevier Science Inc.
引用
收藏
页码:320 / 323
页数:4
相关论文
共 40 条
  • [1] THE PREDICTIVE VALUE OF MICROALBUMINURIA IN IDDM - A 5-YEAR FOLLOW-UP-STUDY
    ALMDAL, T
    NORGAARD, K
    FELDTRASMUSSEN, B
    DECKERT, T
    [J]. DIABETES CARE, 1994, 17 (02) : 120 - 125
  • [2] ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
  • [3] EFFECT OF GLYCEMIC CONTROL ON EARLY DIABETIC RENAL LESIONS - A 5-YEAR RANDOMIZED CONTROLLED CLINICAL-TRIAL OF INSULIN-DEPENDENT DIABETIC KIDNEY-TRANSPLANT RECIPIENTS
    BARBOSA, J
    STEFFES, MW
    SUTHERLAND, DER
    CONNETT, JE
    RAO, KV
    MAUER, SM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (08): : 600 - 606
  • [4] RENAL PROTECTIVE EFFECT OF ENALAPRIL IN DIABETIC NEPHROPATHY
    BJORCK, S
    MULEC, H
    JOHNSEN, SA
    NORDEN, G
    AURELL, M
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6823): : 339 - 343
  • [5] DECLINING INCIDENCE OF NEPHROPATHY IN INSULIN-DEPENDENT DIABETES-MELLITUS
    BOJESTIG, M
    ARNQVIST, HJ
    HERMANSSON, G
    KARLBERG, BE
    LUDVIGSSON, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (01) : 15 - 18
  • [6] IS DIABETIC NEPHROPATHY AN INHERITED COMPLICATION
    BORCHJOHNSEN, K
    NORGAARD, K
    HOMMEL, E
    MATHIESEN, ER
    JENSEN, JS
    DECKERT, T
    PARVING, HH
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (04) : 719 - 722
  • [7] BORCHJOHNSEN K, 1985, AM J MED, V78, P785
  • [8] NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE
    BORDER, WA
    NOBLE, NA
    YAMAMOTO, T
    HARPER, JR
    YAMAGUCHI, Y
    PIERSCHBACHER, MD
    RUOSLAHTI, E
    [J]. NATURE, 1992, 360 (6402) : 361 - 364
  • [9] BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
  • [10] DETECTION AND MANAGEMENT OF EARLY DIABETIC NEPHROPATHY
    CRANDALL, JP
    APPEL, GB
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1993, 4 (07) : 232 - 237